These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1171238)

  • 21. N alpha-arylsulfonyl-omega-amidinophenyl-alpha-aminoalkyl-carboxylic acid amides as specific thrombin inhibitors.
    Stürzebecher J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):83-8. PubMed ID: 6177613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of N-[2-[5-[Amino(imino)methyl]-2-hydroxyphenoxy]-3, 5-difluoro-6-[3-(4, 5-dihydro-1-methyl-1H-imidazol-2-yl)phenoxy]pyridin-4-yl]-N-methylgl y cine (ZK-807834): a potent, selective, and orally active inhibitor of the blood coagulation enzyme factor Xa.
    Phillips GB; Buckman BO; Davey DD; Eagen KA; Guilford WJ; Hinchman J; Ho E; Koovakkat S; Liang A; Light DR; Mohan R; Ng HP; Post JM; Shaw KJ; Smith D; Subramanyam B; Sullivan ME; Trinh L; Vergona R; Walters J; White K; Whitlow M; Wu S; Xu W; Morrissey MM
    J Med Chem; 1998 Sep; 41(19):3557-62. PubMed ID: 9733480
    [No Abstract]   [Full Text] [Related]  

  • 23. [Synthetic inhibitors of serine proteinases. 5. The inhibition of trypsin, plasmin and thrombin caused by aliphatic amidino compounds having ether structure as well as esters of the 3- and 4-amidinophenoxyfacetic acid].
    Walsmann P; Horn H; Landmann H; Markwardt F; Stürzebecher J; Wagner G
    Pharmazie; 1975 Jun; 30(6):386-9. PubMed ID: 125879
    [No Abstract]   [Full Text] [Related]  

  • 24. New synthetic inhibitors of C1r, C1 esterase, thrombin, plasmin, kallikrein and trypsin.
    Fujii S; Hitomi Y
    Biochim Biophys Acta; 1981 Oct; 661(2):342-5. PubMed ID: 6271224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aromatic amidines: comparison of their ability to block respiratory syncytial virus induced cell fusion and to inhibit plasmin, urokinase, thrombin, and trypsin.
    Tidwell RR; Geratz JD; Dubovi EJ
    J Med Chem; 1983 Feb; 26(2):294-8. PubMed ID: 6219223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure-activity relationships of substituted benzothiophene-anthranilamide factor Xa inhibitors.
    Chou YL; Davey DD; Eagen KA; Griedel BD; Karanjawala R; Phillips GB; Sacchi KL; Shaw KJ; Wu SC; Lentz D; Liang AM; Trinh L; Morrissey MM; Kochanny MJ
    Bioorg Med Chem Lett; 2003 Feb; 13(3):507-11. PubMed ID: 12565961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biochemical and pharmacological effects of the direct thrombin inhibitor AR-H067637.
    Deinum J; Mattsson C; Inghardt T; Elg M
    Thromb Haemost; 2009 Jun; 101(6):1051-9. PubMed ID: 19492147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Synthetic serine protease inhibitors. 29. Synthesis of alpha-arylsulphonylamino-beta-(4-amidinophenyl)ethyl-chloromethylketones and their inhibitory activity against trypsin, plasmin and thrombin].
    Horn H; Wagner G; Stürzebecher J; Walsmann P; Markwardt F
    Pharmazie; 1983 Sep; 38(9):581-4. PubMed ID: 6227920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ethyl esters of N-(3- and N-(4-amidinobenzoyl)(-L-)amino acids: synthesis and antiproteolytic activity towards bovine trypsin and porcine pancreatic kallikrein.
    Ferroni R; Menegatti E; Orlandini P; Scalia S; Guarneri M; Bolognesi M; Ascenzi P
    Farmaco Sci; 1985 Oct; 40(10):717-29. PubMed ID: 3853512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis, and in vitro biological activity of indole-based factor Xa inhibitors.
    Arnaiz DO; Zhao Z; Liang A; Trinh L; Witlow M; Koovakkat SK; Shaw KJ
    Bioorg Med Chem Lett; 2000 May; 10(9):957-61. PubMed ID: 10853668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism-based isocoumarin inhibitors for trypsin and blood coagulation serine proteases: new anticoagulants.
    Kam CM; Fujikawa K; Powers JC
    Biochemistry; 1988 Apr; 27(7):2547-57. PubMed ID: 3164217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. On the irreversible inhibition of alpha-chymotrypsin, trypsin, pancreatic kallikrein, thrombin and elastase by N-(beta-pyridylmethyl)-3,4-dichlorophenoxyacetamide-p-fluorosulfonylacetanilide bromide.
    Geratz JD; Fox LL
    Biochim Biophys Acta; 1973 Sep; 321(1):296-302. PubMed ID: 4796088
    [No Abstract]   [Full Text] [Related]  

  • 33. Inhibition of six serine proteinases of the human coagulation system by mutants of bovine pancreatic trypsin inhibitor.
    Grzesiak A; Krokoszynska I; Krowarsch D; Buczek O; Dadlez M; Otlewski J
    J Biol Chem; 2000 Oct; 275(43):33346-52. PubMed ID: 10930417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitory effects of -guanidino acid esters on trypsin, plasmin, plasma kallikrein and thrombin.
    Muramatu M; Fujii S
    Biochim Biophys Acta; 1972 Apr; 268(1):221-4. PubMed ID: 4259678
    [No Abstract]   [Full Text] [Related]  

  • 35. Inhibitory effect of a new synthetic protease inhibitor (FUT-175) on the coagulation system.
    Hitomi Y; Ikari N; Fujii S
    Haemostasis; 1985; 15(3):164-8. PubMed ID: 3161808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mouse plasma trypsin inhibitors: inhibitory spectrum of contrapsin and alpha-1-antitrypsin.
    Takahara H; Sinohara H
    Thromb Res; 1982 Jul; 27(1):45-50. PubMed ID: 6214866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
    Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE
    J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of glandular and plasma kallikrein by benzamidine derivatives.
    Stürzebecher J; Vieweg H; Prasa D
    Agents Actions Suppl; 1992; 38 ( Pt 1)():190-7. PubMed ID: 1466270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacious and orally bioavailable thrombin inhibitors based on a 2,5-thienylamidine at the P1 position: discovery of N-carboxymethyl-d-diphenylalanyl-l-prolyl[(5-amidino-2-thienyl)methyl]amide.
    Lee K; Park CW; Jung WH; Park HD; Lee SH; Chung KH; Park SK; Kwon OH; Kang M; Park DH; Lee SK; Kim EE; Yoon SK; Kim A
    J Med Chem; 2003 Aug; 46(17):3612-22. PubMed ID: 12904065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel amidine-containing peptidyl phosphonates as irreversible inhibitors for blood coagulation and related serine proteases.
    Oleksyszyn J; Boduszek B; Kam CM; Powers JC
    J Med Chem; 1994 Jan; 37(2):226-31. PubMed ID: 8295209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.